ResearcherLeiden University Medical CenterActive in the last 2 years

Tom J. Harryvan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0386-8302; OpenAlex author ID A5053528626. Sources: OpenAlex.

Their work

Papers: 3 (first author 2, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

ZEB1, a novel junctional adhesion molecule A regulator, impacts sensitivity of pancreatic cancer-associated fibroblasts to reovirus. First author DOI 10.1016/j.omton.2025.201071 ↗
Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pancreatic ductal adenocarcinoma. First author DOI 10.1002/1878-0261.13561 ↗
A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differentiation. Co-author DOI 10.1016/j.gastha.2022.04.019 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Vera Kemp · 2 shared papers, 2024–2025 · strength 0.52
- Paper ZEB1, a novel junctional adhesion molecule A regulator, impacts sensitivity of pancreatic cancer-associated fibroblasts… DOI 10.1016/j.omton.2025.201071 ↗
- Paper Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pa… DOI 10.1002/1878-0261.13561 ↗
Lukas J.A.C. Hawinkels · 2 shared papers, 2022–2025 · strength 0.41
- Paper ZEB1, a novel junctional adhesion molecule A regulator, impacts sensitivity of pancreatic cancer-associated fibroblasts… DOI 10.1016/j.omton.2025.201071 ↗
- Paper A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differ… DOI 10.1016/j.gastha.2022.04.019 ↗
Nicole Dam · 1 shared paper, 2025 · strength 0.28
- Paper ZEB1, a novel junctional adhesion molecule A regulator, impacts sensitivity of pancreatic cancer-associated fibroblasts… DOI 10.1016/j.omton.2025.201071 ↗
Rob C. Hoeben · 1 shared paper, 2024 · strength 0.24
- Paper Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pa… DOI 10.1002/1878-0261.13561 ↗
Selas T. F. Bots · 1 shared paper, 2024 · strength 0.24
- Paper Preclinical evaluation of the gorilla-derived HAdV-B AdV-lumc007 oncolytic adenovirus 'GoraVir' for the treatment of pa… DOI 10.1002/1878-0261.13561 ↗
Marten Hornsveld · 1 shared paper, 2022 · strength 0.13
- Paper A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differ… DOI 10.1016/j.gastha.2022.04.019 ↗
Carina Strell · 1 shared paper, 2022 · strength 0.13
- Paper A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differ… DOI 10.1016/j.gastha.2022.04.019 ↗
Jeanin Elise van Hooft · 1 shared paper, 2022 · strength 0.13
- Paper A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differ… DOI 10.1016/j.gastha.2022.04.019 ↗
Peter ten Dijke · 1 shared paper, 2022 · strength 0.13
- Paper A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differ… DOI 10.1016/j.gastha.2022.04.019 ↗
Arne Östman · 1 shared paper, 2022 · strength 0.13
- Paper A Novel Pancreatic Cancer Mini-tumor Model to Study Desmoplasia and Myofibroblastic Cancer-Associated Fibroblast Differ… DOI 10.1016/j.gastha.2022.04.019 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.